May 2, 2019 (Global Newswire) — Cambridge, MAAgios Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved its supplem···【Read More】
Update: 2026-05-06Source: Haiou HealthViews: 108
August 25, 2021 – BostonServier Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Ivosidenib for the treatment o···【Read More】
Update: 2026-05-06Source: Haiou HealthViews: 112
May 25, 2022, BostonServier announced that the U.S. Food and Drug Administration (FDA) has approved ivonidenib in combination with azacitidine for the···【Read More】
Update: 2026-05-06Source: Haiou HealthViews: 109
October 24, 2023, Boston, USAServier announced that the U.S. Food and Drug Administration (FDA) has approved ivonidenib for the treatment of patients ···【Read More】
Update: 2026-05-06Source: Haiou HealthViews: 109
Ivosidenib is used to treat acute myeloid leukemia (AML), cholangiocarcinoma, and myelodysplastic syndromes (MDS) in adult patients with isocitrate de···【Read More】
Update: 2026-05-06Source: Haiou HealthViews: 110
While taking Selumetinib, you should attend regular follow-up appointments and remain alert to potential risks such as pregnancy complications, cardia···【Read More】
Update: 2026-04-30Source: Haiou HealthViews: 111
On May 28, 2021, Amgen (NASDAQ: AMGN) announced that the U.S. Food and Drug Administration (FDA) has approved sotorasib for the treatment of adult pat···【Read More】
Update: 2026-04-29Source: Haiou HealthViews: 130
On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) in combination with Vectibix (···【Read More】
Update: 2026-04-27Source: Haiou HealthViews: 131
Sotorasib is an oral targeted cancer therapy drug that received U.S. FDA approval in May 2021 (marketed under the brand name Lumakras). It is indicate···【Read More】
Update: 2026-04-27Source: Haiou HealthViews: 120
Selinexor is an XPO-1 inhibitor clinically used to treat multiple myeloma and diffuse large B-cell lymphoma. It has shown good efficacy, improving obj···【Read More】
Update: 2026-04-24Source: Haiou HealthViews: 126
Thrombocytopenia is a common adverse reaction during celinoxetine treatment. Whether or not to discontinue the medication depends primarily on its sev···【Read More】
Update: 2026-04-23Source: Haiou HealthViews: 131
Xpovio (Selinexor) is a medication used to treat multiple myeloma in adults. Genuine Xpovio can be purchased in various safe and reliable ways, and pa···【Read More】
Update: 2026-04-22Source: Haiou HealthViews: 130
Where is a reliable place to buy selinexor?When purchasing selinexor, patients should choose reputable and legitimate channels, such as hospital pharm···【Read More】
Update: 2026-04-22Source: Haiou HealthViews: 126
Generic versions of Selinexor offer patients a more affordable treatment option; however, the channels used for purchasing them must be chosen with ca···【Read More】
Update: 2026-04-20Source: Haiou HealthViews: 128
Selinexor is a novel targeted anticancer drug that has shown significant efficacy in treating multiple myeloma and diffuse large B-cell lymphoma, but ···【Read More】
Update: 2026-04-17Source: Haiou HealthViews: 131
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos